“…With respect to the inflammation, the affinity to the substrate (biotinyl-6-aminoquinoline) of biotinidase (Amo) in inflammatory disease is also found to be significantly increased; i.e., median Amo in inflammatory diseases (n=10) is 23.9 s -1 x M -1 and that in healthy control (n=8) is 19.4 s -1 x M -1 , respectively (p<0.002; Mann-Whitney's U test, two-tailed test). This finding is in line with the previous finding that specific activity (V) of biotinidase is instantaneously elevated in cerebrospinal fluid of a Staphylococcus aureus meningitis patient [18]. Surprisingly, protein amount of biotinidase in the serum is not changed by the oral biotin-administration at all; i.e., Child patient 1 from 0.19 to 0.19 mg/mL, Child patient 2 from 0.20 to 0.22 mg/mL, and Child patient 3 from 0.25 to 0.21 mg/mL before and after the biotin treatment, respectively (Table 1 and Supplementary data 3).…”